Pharmaceutical — Goodwill, related to acquisitions
Business Segments · Goodwill, related to acquisitionsJohnson & Johnson Pharmaceutical — Goodwill, related to acquisitions decreased by 101.0% to -$30.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 152.6%, from $57.00M to -$30.00M.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ3 2025
How to read this metric
Higher values indicate aggressive inorganic growth and investment in future pipeline expansion.
Detailed definition
Captures the specific portion of goodwill added to the Innovative Medicine segment balance sheet resulting from inorgani...
Peer comparison
Comparable to 'Acquisition-related Goodwill' in segment disclosures for life sciences peers.
Metric ID:
jnj_segment_innovative_medicine_goodwill_related_to_acquisitionsHistorical Data
10 periods
| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $290.00M | $273.00M | $57.00M | $20.00M | $0.00 | $2.88B | -$30.00M |
| QoQ Change | — | — | — | — | -5.9% | -79.1% | -64.9% | -100.0% | — | -101.0% |
| YoY Change | — | — | — | — | — | — | — | -100.0% | +953.5% | -152.6% |
Range-$30.00M – $2.88B
Avg YoY Growth+233.6%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's pharmaceutical — goodwill, related to acquisitions?
- Johnson & Johnson (JNJ) reported pharmaceutical — goodwill, related to acquisitions of -$30.00M in Q3 2025.
- How has Johnson & Johnson's pharmaceutical — goodwill, related to acquisitions changed year-over-year?
- Johnson & Johnson's pharmaceutical — goodwill, related to acquisitions decreased by 152.6% year-over-year, from $57.00M to -$30.00M.
- What does pharmaceutical — goodwill, related to acquisitions mean?
- The amount of goodwill added to the Innovative Medicine segment due to new acquisitions.